These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34285312)

  • 1. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
    Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
    Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.
    Weston G; Giri A; Komarow L; Ge L; Baum KR; Abbenante E; Gallagher JC; Jacob JT; Kaye KS; Kim AC; Huskins WC; Zervos M; Herc E; Patel R; Van Duin D; Doi Y
    J Antimicrob Chemother; 2024 Aug; 79(8):1929-1937. PubMed ID: 38863337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
    Zhou H; Buetti N; Pérez-Galera S; Bravo-Ferrer J; Gutiérrez-Gutiérrez B; Paniagua-García M; Feifel J; Sauser J; Kostyanev T; Canton R; Tan LK; Basoulis D; Pintado V; Roilides E; Dragovac G; Torre-Cisneros J; Mediç D; Akova M; Goossens H; Bonten M; Harbarth S; Rodriguez-Baño J; De Kraker MEA;
    J Antimicrob Chemother; 2024 Sep; 79(9):2132-2141. PubMed ID: 38988305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
    Hoffman T; Lellouche J; Nutman A; Temkin E; Frenk S; Harbarth S; Carevic B; Cohen-Percia S; Kariv Y; Fallach N; Klausner J; Carmeli Y;
    Clin Microbiol Infect; 2021 Oct; 27(10):1481-1487. PubMed ID: 33588061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment.
    Miller BM; Johnson SW
    Am J Infect Control; 2016 Feb; 44(2):134-7. PubMed ID: 26492818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [External Validation of Carbapenem-Resistant
    Seo SM; Jeong IS
    J Korean Acad Nurs; 2020 Aug; 50(4):621-630. PubMed ID: 32895347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns.
    Han SB; Jeon K; Kim M; Park J; Yoon J; Cho YS; Hur J; Chun W; Kym D
    J Hosp Infect; 2024 Jul; 149():165-171. PubMed ID: 38740304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting.
    Holmgren A; Ljung A; Bremell D
    Infect Dis (Lond); 2020 Apr; 52(4):242-248. PubMed ID: 31868053
    [No Abstract]   [Full Text] [Related]  

  • 15. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.
    Lin Q; Wang Y; Yu J; Li S; Zhang Y; Wang H; Lai X; Liu D; Mao L; Luo Y; Tang G; Chen Z; Sun Z
    BMC Infect Dis; 2021 Jul; 21(1):638. PubMed ID: 34215214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    Teo J; Cai Y; Tang S; Lee W; Tan TY; Tan TT; Kwa AL
    PLoS One; 2012; 7(3):e34254. PubMed ID: 22461908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors and clinical prognosis analysis of carbapenem-resistant
    Zhang AR; Wang Q; Zhou CE; Zhang JG; Wang XJ; Zhao JK; Lu BH; Yang CX; Gu L; Ma LY; Su JR; Cao B; Wang H
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(21):1572-1582. PubMed ID: 34098684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.